Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:33:21.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision displayed changed from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T01:03:38.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Site update to revision v3.4.2; the funding/operating status notice has been removed and there are no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:34:29.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Notice banner warns that information may not be up to date due to a lapse in government funding and provides operating status links. The page revision changed from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:43:35.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    A glossary toggle was added and QC-related labels were updated (Last Update Submitted that Met QC Criteria added; the previous 'met QC Criteria' label removed). The revision tag changes from v3.3.4 to v3.4.0 and the No FEAR Act data capitalization was adjusted.
    Difference
    0.2%
    Check dated 2026-01-28T04:43:35.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page revision shows v3.3.4 replacing v3.3.3, with no substantive changes to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:13:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.